Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutic...
24th July, 2025
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutic...
24th July, 2025
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Roche is considering selling its prescription med...
24th July, 2025
By Danilo Masoni MILAN (Reuters) -Global healthcare stocks have not been this cheap in decades and f...
23rd July, 2025
By Rishika Sadam HYDERABAD (Reuters) -Dr Reddy's Laboratories plans to launch a cheaper copycat vers...
23rd July, 2025
(Reuters) -Roche Holding AG paused all shipments of the controversial gene therapy Elevidys, Bloombe...
22nd July, 2025
LONDON (Reuters) -A planned junior doctors' strike in England will go ahead this week, their trade u...
22nd July, 2025
By Nidal al-Mughrabi CAIRO/GAZA (Reuters) -A six-week-old infant was among 15 people who have died o...
22nd July, 2025
By Nancy Lapid and Jennifer Rigby (Reuters) -Eight children in the UK have been spared from devastat...
16th July, 2025

(Reuters) -KKR is considering a potential buyout of Italian health-care technology firm GPI SpA, as...
16th July, 2025
By Pushkala Aripaka (Reuters) -AstraZeneca's experimental therapy anselamimab did not meet the main...
16th July, 2025
By Olivia Le Poidevin GENEVA (Reuters) -One in 10 children screened in clinics run by the United Nat...
15th July, 2025
(Reuters) -AstraZeneca's experimental drug baxdrostat has been successful in lowering high blood pre...
14th July, 2025